KCNH2 and cancer: Overall, the present study explains (i) the mechanism underlying the aberrant expression of hERG1 in cancer, (ii) how integrin receptors stimulate IhERG1, and (iii) how hERG1 and β1 integrins interact to produce a slow cycle of expression on the plasma membrane, which matches the protrusion/retraction cycle in cell migration.